Healthcare provider profile · identity verified

Gregory Hightower, MD

Family Practice · BARTLESVILLE, OK · NPI 1700222189

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	501	149
Lisinopril	Lisinopril	233	87
Levothyroxine Sodium	Levothyroxine Sodium	216	59
Amlodipine Besylate	Amlodipine Besylate	206	60
Losartan Potassium	Losartan Potassium	206	57
Trazodone Hcl	Trazodone Hcl	163	45
Gabapentin	Gabapentin	160	50
Omeprazole	Omeprazole	158	46
Albuterol Sulfate Hfa	Albuterol Sulfate	146	40
Pantoprazole Sodium	Pantoprazole Sodium	131	43
Citalopram Hbr	Citalopram Hydrobromide	128	35
Metformin Hcl Er	Metformin Hcl	128	42
Hydrochlorothiazide	Hydrochlorothiazide	123	44
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	122	22
Rosuvastatin Calcium	Rosuvastatin Calcium	122	41
Meloxicam	Meloxicam	111	27
Montelukast Sodium	Montelukast Sodium	100	35
Fluoxetine Hcl	Fluoxetine Hcl	99	23
Zolpidem Tartrate	Zolpidem Tartrate	98	15
Ozempic	Semaglutide	97	18
Sertraline Hcl	Sertraline Hcl	89	30
Diclofenac Sodium	Diclofenac Sodium	86	20
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	84	14
Buspirone Hcl	Buspirone Hcl	82	30
Metoprolol Succinate	Metoprolol Succinate	80	27
Metoprolol Tartrate	Metoprolol Tartrate	80	25
Escitalopram Oxalate	Escitalopram Oxalate	79	24
Tamsulosin Hcl	Tamsulosin Hcl	78	22
Clonazepam	Clonazepam	75	14
Allopurinol	Allopurinol	74	22
Potassium Chloride	Potassium Chloride	69	19
Hydroxyzine Hcl	Hydroxyzine Hcl	63	suppressed
Trulicity	Dulaglutide	63	12
Alprazolam	Alprazolam	62	suppressed
Furosemide	Furosemide	60	21
Metformin Hcl	Metformin Hcl	60	16
Duloxetine Hcl	Duloxetine Hcl	57	17
Famotidine	Famotidine	56	15
Nifedipine Er	Nifedipine	56	15
Carvedilol	Carvedilol	53	13
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	53	16
Fluticasone Propionate	Fluticasone Propionate	51	17
Mounjaro	Tirzepatide	51	suppressed
Aripiprazole	Aripiprazole	50	suppressed
Tramadol Hcl	Tramadol Hcl	50	suppressed
Glipizide Er	Glipizide	49	14
Eliquis	Apixaban	46	12
Simvastatin	Simvastatin	46	15
Bupropion Xl	Bupropion Hcl	43	12
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	41	suppressed
Ropinirole Hcl	Ropinirole Hcl	41	13
Finasteride	Finasteride	39	suppressed
Baclofen	Baclofen	38	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	35	11
Pregabalin	Pregabalin	34	12
Quetiapine Fumarate	Quetiapine Fumarate	34	suppressed
Clonidine Hcl	Clonidine Hcl	33	suppressed
Jardiance	Empagliflozin	33	suppressed
Tizanidine Hcl	Tizanidine Hcl	33	suppressed
Lorazepam	Lorazepam	30	12
Memantine Hcl	Memantine Hcl	29	suppressed
Synthroid	Levothyroxine Sodium	29	11
Donepezil Hcl	Donepezil Hcl	27	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	27	suppressed
Clopidogrel	Clopidogrel Bisulfate	26	suppressed
Ondansetron Odt	Ondansetron	26	11
Estradiol	Estradiol	25	suppressed
Tresiba Flextouch U-100	Insulin Degludec	25	11
Xultophy 100-3.6	Insulin Degludec/Liraglutide	25	suppressed
Morphine Sulfate Er	Morphine Sulfate	23	suppressed
Temazepam	Temazepam	23	suppressed
Topiramate	Topiramate	23	suppressed
Torsemide	Torsemide	23	suppressed
Levetiracetam	Levetiracetam	22	suppressed
Prednisone	Prednisone	22	14
Xarelto	Rivaroxaban	22	suppressed
Atenolol	Atenolol	21	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	21	suppressed
Celecoxib	Celecoxib	21	suppressed
Pravastatin Sodium	Pravastatin Sodium	21	suppressed
Glipizide	Glipizide	20	suppressed
Ondansetron Hcl	Ondansetron Hcl	20	suppressed
Breo Ellipta	Fluticasone/Vilanterol	19	suppressed
Hydralazine Hcl	Hydralazine Hcl	19	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	19	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	19	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	19	suppressed
Divalproex Sodium Er	Divalproex Sodium	18	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	18	suppressed
Lidocaine	Lidocaine	18	suppressed
Myrbetriq	Mirabegron	18	suppressed
Valsartan	Valsartan	18	suppressed
Paroxetine Hcl	Paroxetine Hcl	17	suppressed
Symbicort	Budesonide/Formoterol Fumarate	17	suppressed
Ventolin Hfa	Albuterol Sulfate	17	suppressed
Fluconazole	Fluconazole	16	suppressed
Humalog Kwikpen U-100	Insulin Lispro	16	suppressed
Lovastatin	Lovastatin	16	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	15	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	15	suppressed
Ibuprofen	Ibuprofen	15	suppressed
Benazepril Hcl	Benazepril Hcl	14	suppressed
Diazepam	Diazepam	14	suppressed
Prochlorperazine Maleate	Prochlorperazine Maleate	14	suppressed
Rybelsus	Semaglutide	14	suppressed
Tetrabenazine	Tetrabenazine	14	suppressed
Abilify Maintena	Aripiprazole	13	suppressed
Enalapril Maleate	Enalapril Maleate	13	suppressed
Flunisolide	Flunisolide	13	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	13	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	13	suppressed
Metolazone	Metolazone	13	suppressed
Morphine Sulfate	Morphine Sulfate	13	suppressed
Propranolol Hcl Er	Propranolol Hcl	13	suppressed
Amlodipine-Atorvastatin	Amlodipine/Atorvastatin	12	suppressed
Bydureon Bcise	Exenatide Microspheres	12	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	12	suppressed
Eszopiclone	Eszopiclone	12	suppressed
Januvia	Sitagliptin Phosphate	12	suppressed
Methadone Hcl	Methadone Hcl	12	suppressed
Propranolol Hcl	Propranolol Hcl	12	suppressed
Testosterone Cypionate	Testosterone Cypionate	12	suppressed
Vilazodone Hcl	Vilazodone Hcl	12	suppressed
Cephalexin	Cephalexin	11	suppressed
Lamotrigine	Lamotrigine	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error